Melqart Asset Management (UK) Ltd

Position in APGE — Apogee Therapeutics, Inc.

CIK 1712901 London, X0

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$15,562,459

New position

Shares Held

117,249

first reported quarter

Ownership

0.155%

of shares outstanding

% of Portfolio

1.58%

of 13F equity value

Holder Rank

#73

of 285 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Melqart Asset Management (UK) Ltd holds $144,610,610 across 5 Biotechnology names. APGE ranks #4 (10.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	767,525	$65,385,454
2	ABVX	Abivax S.A.	307,250	$40,944,135
3	RVMD	Revolution Medicines, Inc.	121,308	$22,718,562
4	APGE	Apogee Therapeutics, Inc. This page	117,249	$15,562,459
5	CPRX	Catalyst Pharmaceuticals, Inc.	247,556	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,562,459	117,249	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.